Menu

In the News

Press Releases

FILTER BY

Frost & Sullivan Evaluates the Future of Corporate Transactions Reshaped by COVID-19

Frost & Sullivan Evaluates the Future of Corporate Transactions Reshaped by COVID-19

Frost & Sullivan invites you to the upcoming webinar, “Prepare for the Future of Corporate Transactions,” on Nov. 18, 2020 at 2 p.m. GMT / 9 a.m. EST. Join Frost & Sullivan Business & Financial Services experts George Galanopoulos, Sanjay Singh, and Akhil Bajaj, to discover the key fundamental changes brought about by COVID-19 in the M&A process and how this can be optimized in the new normal.

Impact of the Coronavirus on Business

Impact of the Coronavirus on Business

The coronavirus outbreak ensured that the Year of the Rat didn’t get off to the most propitious start. Over 2,000 people dead so far, more than 80,000 infected and 40+ countries affected. Cities in lockdown, travel restrictions in place, plant closures mounting....

Materials are Key to Meeting the Growth in Demand for Li-ion Batteries

Materials are Key to Meeting the Growth in Demand for Li-ion Batteries

Having chalked up lacklustre growth in 2019,  global electric vehicle sales registered a sharp surge (+35% YoY) in 2020, defying the pandemic, ensuing containment measures and supply disruptions. In sharp contrast to the plummeting sales of conventional ICE vehicles, down by 14%, global EV sales volumes were estimated at nearly 3.1 million units in 2020. EVs represented nearly a tenth of total vehicle sales in Europe in 2020.

Leading and Empowering Talent for Business Success

Leading and Empowering Talent for Business Success

Frost & Sullivan is pleased to announce that Roland Cloutier, Corporate Vice President and Global Chief Security Officer, ADP, will be the second-day headliner at the 14th Annual New Product Innovation & Development: A Frost & Sullivan Executive MindXchange, on March 23-26, 2020, at the Loews Royal Pacific Resort in Orlando, Florida.

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan’s recent analysis finds that digital therapeutics (DTx) in the United States are considered legitimate alternatives to traditional pharmacotherapy. These solutions are comprehensively regulated and granted prescription status by various national or state-level regulatory agencies based on reported evidence of improved clinical outcomes for a defined patient population.

2019 CC Awards – Kahuna Winners Announced

2019 CC Awards – Kahuna Winners Announced

The CC Awards Program honors companies and individual leaders that are shaping the future of customer service. Honored recipients have demonstrated achievement in one or more of five categories: Analytics, Artificial Intelligence, Process Automation, Self Service and Social Media.

Have Questions?

We have Answers.

Schedule a Complimentary Growth Pipeline Dialog™
with an Industry Expert

Call Frost & Sullivan Icon

877.GoFrost

(877.463.7678)

Email Frost & Sullivan

myfrost@frost.com

X